Abstract
Sick sinus syndrome is an indication for pacemaker implantation in 30–50% of all patients who receive a pacemaker. In these patients tachycardia — atrial fibrillation, atrial flutter, atrial tachycardia — is a frequent rhythmologic event [1]. About 20% of patients with sick sinus syndrome who receive a pacemaker are suffering from paroxysmal tachycardia. At the present time digitalis and antiarrhythmic drugs are used to suppress tachycardias or at least to prevent a critical increase of the heart rate.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Steinbach K, Frohner K, Meisl F, Podczeck A, Unger G. Epidemiology of bradyarrhythmia. In Pistolese M., Santini M (eds): Progress in clinical pacing. Rome: Luigi Pozzi 1984; 5–12.
Nitsch G, Müller B, Steinbach K. Paroxysmal atrial fibrillation: Can the time interval till first recurrence be predicted. Cardiologia Hungarica 1995; 3: 15 (abstr).
Morillo Ca, Klein GJ, Jones LJ, Guiranda CM. Chronic rapid atrial pacing: Structural, functional and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995; 91: 1588–95.
Centurion OA, Shojiro J, Shimizu A et al. Supernormal atrial conduction and its relation to atrial vulnerability and atrial fibrillation in patients with sick sinus syndrome and paroxysmal atrial fibrillation. Am Heart J 1994; 128: 88–95.
Santini M, Alexidou G, Ansalone G, Cacciatore G, Cini R, Turitto G. Relation of prognosis in sick sinus node syndrome to age, conduction defects and modes of permanent pacing. Am J Cardiol 1990; 65: 729–35.
Nürnberg M, Frohner K, Podczeck A, Steinbach K. Is VVI pacing more dangerous than AV sequential pacing in patients with sick sinus node syndrome. Pace 1991; 14: 227 (abstr).
Prakash A, Saksena S, Hill M et al. Outcome of patients with drug refractory atrial fibrillation/flutter and bradyarrhythmias using long-term dual site atrial pacing. PACE 1995; 18: 809 (abstr).
Seidl KH, Hauer B, Schwick N, Büchele T, Senges J. Is the site of atrial lead implantation in dual chamber pacing of importance for preventing atrial fibrillation ? The hidden benefits of lead implantation in the right atrial appendix. PACE 1995; 18: 810 (abstr).
Stern R. Atrial fibrillation following pacemaker implantation: Influence of the underlying pacing rate. PACE 1995; 18: 883 (abstr).
Steinbach K, Scheibelhofer W, Joskowicz G, Haagen T. 10 Jahre zentrale Dokumentation der Schrittmachertherapie in Österreich. Herzschr. Elektrophysiol 1991; 2: 85–91.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Steinbach, K.K., Nürnberg, M., Rymaz, P. (1996). Pacing to prevent arrhythmias: bradycardia/tachycardia syndrome. In: Oto, M.A. (eds) Practice and Progress in Cardiac Pacing and Electrophysiology. Developments in Cardiovascular Medicine, vol 183. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0219-0_19
Download citation
DOI: https://doi.org/10.1007/978-94-009-0219-0_19
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6582-5
Online ISBN: 978-94-009-0219-0
eBook Packages: Springer Book Archive